IOM calls for more global collaboration to protect drug supply
This article was originally published in Scrip
Executive Summary
To safeguard and improve the US drug and food supply chain, the FDA needs to work more closely with its "technologically advanced" counterparts in the European Union and other developed nations, such as Canada, Japan and New Zealand, to plan a regulatory system for mutual recognition of one another's inspections, with the goal of eliminating wasteful, duplicative efforts, the Institute of Medicine (IOM) urged in a new report.
You may also be interested in...
Moderna's Valera Takes mRNA Approach To Combat Zika
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan's Price Reform Pledge: Will Others Follow?
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Clinton's Drug Price Plan: Threat Or Flash In The Political Pan?
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.